Table of Content

1 Opioid Induced Constipation (OlC) Drugs Market Overview
1.1 Product Overview and Scope of Opioid Induced Constipation (OlC) Drugs
1.2 Opioid Induced Constipation (OlC) Drugs Segment by Type
1.2.1 Global Opioid Induced Constipation (OlC) Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Over the Counter Drugs
1.2.3 Prescribed Drugs
1.3 Opioid Induced Constipation (OlC) Drugs Segment by Application
1.3.1 Global Opioid Induced Constipation (OlC) Drugs Market Value by Application: (2024-2034)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Opioid Induced Constipation (OlC) Drugs Market Size Estimates and Forecasts
1.4.1 Global Opioid Induced Constipation (OlC) Drugs Revenue 2018-2029
1.4.2 Global Opioid Induced Constipation (OlC) Drugs Sales 2018-2029
1.4.3 Global Opioid Induced Constipation (OlC) Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Opioid Induced Constipation (OlC) Drugs Market Competition by Manufacturers
2.1 Global Opioid Induced Constipation (OlC) Drugs Sales Market Share by Manufacturers (2018-2024)
2.2 Global Opioid Induced Constipation (OlC) Drugs Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Opioid Induced Constipation (OlC) Drugs Average Price by Manufacturers (2018-2024)
2.4 Global Opioid Induced Constipation (OlC) Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Opioid Induced Constipation (OlC) Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Opioid Induced Constipation (OlC) Drugs, Product Type & Application
2.7 Opioid Induced Constipation (OlC) Drugs Market Competitive Situation and Trends
2.7.1 Opioid Induced Constipation (OlC) Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Opioid Induced Constipation (OlC) Drugs Players Market Share by Revenue
2.7.3 Global Opioid Induced Constipation (OlC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Opioid Induced Constipation (OlC) Drugs Retrospective Market Scenario by Region
3.1 Global Opioid Induced Constipation (OlC) Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Opioid Induced Constipation (OlC) Drugs Global Opioid Induced Constipation (OlC) Drugs Sales by Region: 2018-2029
3.2.1 Global Opioid Induced Constipation (OlC) Drugs Sales by Region: 2018-2024
3.2.2 Global Opioid Induced Constipation (OlC) Drugs Sales by Region: 2024-2029
3.3 Global Opioid Induced Constipation (OlC) Drugs Global Opioid Induced Constipation (OlC) Drugs Revenue by Region: 2018-2029
3.3.1 Global Opioid Induced Constipation (OlC) Drugs Revenue by Region: 2018-2024
3.3.2 Global Opioid Induced Constipation (OlC) Drugs Revenue by Region: 2024-2029
3.4 North America Opioid Induced Constipation (OlC) Drugs Market Facts & Figures by Country
3.4.1 North America Opioid Induced Constipation (OlC) Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Opioid Induced Constipation (OlC) Drugs Sales by Country (2018-2029)
3.4.3 North America Opioid Induced Constipation (OlC) Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Opioid Induced Constipation (OlC) Drugs Market Facts & Figures by Country
3.5.1 Europe Opioid Induced Constipation (OlC) Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Opioid Induced Constipation (OlC) Drugs Sales by Country (2018-2029)
3.5.3 Europe Opioid Induced Constipation (OlC) Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Opioid Induced Constipation (OlC) Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Opioid Induced Constipation (OlC) Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Opioid Induced Constipation (OlC) Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Opioid Induced Constipation (OlC) Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Opioid Induced Constipation (OlC) Drugs Market Facts & Figures by Country
3.7.1 Latin America Opioid Induced Constipation (OlC) Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Opioid Induced Constipation (OlC) Drugs Sales by Country (2018-2029)
3.7.3 Latin America Opioid Induced Constipation (OlC) Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Opioid Induced Constipation (OlC) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Opioid Induced Constipation (OlC) Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Opioid Induced Constipation (OlC) Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Opioid Induced Constipation (OlC) Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Opioid Induced Constipation (OlC) Drugs Sales by Type (2018-2029)
4.1.1 Global Opioid Induced Constipation (OlC) Drugs Sales by Type (2018-2024)
4.1.2 Global Opioid Induced Constipation (OlC) Drugs Sales by Type (2024-2029)
4.1.3 Global Opioid Induced Constipation (OlC) Drugs Sales Market Share by Type (2018-2029)
4.2 Global Opioid Induced Constipation (OlC) Drugs Revenue by Type (2018-2029)
4.2.1 Global Opioid Induced Constipation (OlC) Drugs Revenue by Type (2018-2024)
4.2.2 Global Opioid Induced Constipation (OlC) Drugs Revenue by Type (2024-2029)
4.2.3 Global Opioid Induced Constipation (OlC) Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Opioid Induced Constipation (OlC) Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Opioid Induced Constipation (OlC) Drugs Sales by Application (2018-2029)
5.1.1 Global Opioid Induced Constipation (OlC) Drugs Sales by Application (2018-2024)
5.1.2 Global Opioid Induced Constipation (OlC) Drugs Sales by Application (2024-2029)
5.1.3 Global Opioid Induced Constipation (OlC) Drugs Sales Market Share by Application (2018-2029)
5.2 Global Opioid Induced Constipation (OlC) Drugs Revenue by Application (2018-2029)
5.2.1 Global Opioid Induced Constipation (OlC) Drugs Revenue by Application (2018-2024)
5.2.2 Global Opioid Induced Constipation (OlC) Drugs Revenue by Application (2024-2029)
5.2.3 Global Opioid Induced Constipation (OlC) Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Opioid Induced Constipation (OlC) Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Dr. Reddy's Laboratories Ltd.
6.1.1 Dr. Reddy's Laboratories Ltd. Corporation Information
6.1.2 Dr. Reddy's Laboratories Ltd. Description and Business Overview
6.1.3 Dr. Reddy's Laboratories Ltd. Opioid Induced Constipation (OlC) Drugs Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Dr. Reddy's Laboratories Ltd. Opioid Induced Constipation (OlC) Drugs Product Portfolio
6.1.5 Dr. Reddy's Laboratories Ltd. Recent Developments/Updates
6.2 Bausch Health Companies Inc
6.2.1 Bausch Health Companies Inc Corporation Information
6.2.2 Bausch Health Companies Inc Description and Business Overview
6.2.3 Bausch Health Companies Inc Opioid Induced Constipation (OlC) Drugs Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Bausch Health Companies Inc Opioid Induced Constipation (OlC) Drugs Product Portfolio
6.2.5 Bausch Health Companies Inc Recent Developments/Updates
6.3 Pharmaceutical lndustries Ltd.
6.3.1 Pharmaceutical lndustries Ltd. Corporation Information
6.3.2 Pharmaceutical lndustries Ltd. Description and Business Overview
6.3.3 Pharmaceutical lndustries Ltd. Opioid Induced Constipation (OlC) Drugs Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Pharmaceutical lndustries Ltd. Opioid Induced Constipation (OlC) Drugs Product Portfolio
6.3.5 Pharmaceutical lndustries Ltd. Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Corporation Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Opioid Induced Constipation (OlC) Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Novartis AG Opioid Induced Constipation (OlC) Drugs Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Takeda Pharmaceutical Company Limited
6.5.1 Takeda Pharmaceutical Company Limited Corporation Information
6.5.2 Takeda Pharmaceutical Company Limited Description and Business Overview
6.5.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OlC) Drugs Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OlC) Drugs Product Portfolio
6.5.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
6.6 Shionogi & Co., Ltd.
6.6.1 Shionogi & Co., Ltd. Corporation Information
6.6.2 Shionogi & Co., Ltd. Description and Business Overview
6.6.3 Shionogi & Co., Ltd. Opioid Induced Constipation (OlC) Drugs Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Shionogi & Co., Ltd. Opioid Induced Constipation (OlC) Drugs Product Portfolio
6.6.5 Shionogi & Co., Ltd. Recent Developments/Updates
6.7 Mallinckrodt Plc
6.6.1 Mallinckrodt Plc Corporation Information
6.6.2 Mallinckrodt Plc Description and Business Overview
6.6.3 Mallinckrodt Plc Opioid Induced Constipation (OlC) Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Mallinckrodt Plc Opioid Induced Constipation (OlC) Drugs Product Portfolio
6.7.5 Mallinckrodt Plc Recent Developments/Updates
6.8 Merck & Co, Inc.
6.8.1 Merck & Co, Inc. Corporation Information
6.8.2 Merck & Co, Inc. Description and Business Overview
6.8.3 Merck & Co, Inc. Opioid Induced Constipation (OlC) Drugs Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Merck & Co, Inc. Opioid Induced Constipation (OlC) Drugs Product Portfolio
6.8.5 Merck & Co, Inc. Recent Developments/Updates
6.9 Astra Zeneca Plc
6.9.1 Astra Zeneca Plc Corporation Information
6.9.2 Astra Zeneca Plc Description and Business Overview
6.9.3 Astra Zeneca Plc Opioid Induced Constipation (OlC) Drugs Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Astra Zeneca Plc Opioid Induced Constipation (OlC) Drugs Product Portfolio
6.9.5 Astra Zeneca Plc Recent Developments/Updates
6.10 Cosmo Pharmaceuticals
6.10.1 Cosmo Pharmaceuticals Corporation Information
6.10.2 Cosmo Pharmaceuticals Description and Business Overview
6.10.3 Cosmo Pharmaceuticals Opioid Induced Constipation (OlC) Drugs Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Cosmo Pharmaceuticals Opioid Induced Constipation (OlC) Drugs Product Portfolio
6.10.5 Cosmo Pharmaceuticals Recent Developments/Updates
6.11 Teva
6.11.1 Teva Corporation Information
6.11.2 Teva Opioid Induced Constipation (OlC) Drugs Description and Business Overview
6.11.3 Teva Opioid Induced Constipation (OlC) Drugs Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Teva Opioid Induced Constipation (OlC) Drugs Product Portfolio
6.11.5 Teva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Opioid Induced Constipation (OlC) Drugs Industry Chain Analysis
7.2 Opioid Induced Constipation (OlC) Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Opioid Induced Constipation (OlC) Drugs Production Mode & Process
7.4 Opioid Induced Constipation (OlC) Drugs Sales and Marketing
7.4.1 Opioid Induced Constipation (OlC) Drugs Sales Channels
7.4.2 Opioid Induced Constipation (OlC) Drugs Distributors
7.5 Opioid Induced Constipation (OlC) Drugs Customers
8 Opioid Induced Constipation (OlC) Drugs Market Dynamics
8.1 Opioid Induced Constipation (OlC) Drugs Industry Trends
8.2 Opioid Induced Constipation (OlC) Drugs Market Drivers
8.3 Opioid Induced Constipation (OlC) Drugs Market Challenges
8.4 Opioid Induced Constipation (OlC) Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Opioid Induced Constipation (OlC) Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Opioid Induced Constipation (OlC) Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Opioid Induced Constipation (OlC) Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Opioid Induced Constipation (OlC) Drugs Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Opioid Induced Constipation (OlC) Drugs Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Opioid Induced Constipation (OlC) Drugs Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Opioid Induced Constipation (OlC) Drugs Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Opioid Induced Constipation (OlC) Drugs Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Opioid Induced Constipation (OlC) Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Opioid Induced Constipation (OlC) Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Opioid Induced Constipation (OlC) Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Opioid Induced Constipation (OlC) Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Opioid Induced Constipation (OlC) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Constipation (OlC) Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Opioid Induced Constipation (OlC) Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Opioid Induced Constipation (OlC) Drugs Sales by Region (2018-2024) & (K Units)
Table 18. Global Opioid Induced Constipation (OlC) Drugs Sales Market Share by Region (2018-2024)
Table 19. Global Opioid Induced Constipation (OlC) Drugs Sales by Region (2024-2029) & (K Units)
Table 20. Global Opioid Induced Constipation (OlC) Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Opioid Induced Constipation (OlC) Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Opioid Induced Constipation (OlC) Drugs Revenue Market Share by Region (2018-2024)
Table 23. Global Opioid Induced Constipation (OlC) Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Opioid Induced Constipation (OlC) Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Opioid Induced Constipation (OlC) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Opioid Induced Constipation (OlC) Drugs Sales by Country (2018-2024) & (K Units)
Table 27. North America Opioid Induced Constipation (OlC) Drugs Sales by Country (2024-2029) & (K Units)
Table 28. North America Opioid Induced Constipation (OlC) Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Opioid Induced Constipation (OlC) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Opioid Induced Constipation (OlC) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Opioid Induced Constipation (OlC) Drugs Sales by Country (2018-2024) & (K Units)
Table 32. Europe Opioid Induced Constipation (OlC) Drugs Sales by Country (2024-2029) & (K Units)
Table 33. Europe Opioid Induced Constipation (OlC) Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Opioid Induced Constipation (OlC) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Opioid Induced Constipation (OlC) Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Opioid Induced Constipation (OlC) Drugs Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Opioid Induced Constipation (OlC) Drugs Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Opioid Induced Constipation (OlC) Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Opioid Induced Constipation (OlC) Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Opioid Induced Constipation (OlC) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Opioid Induced Constipation (OlC) Drugs Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Opioid Induced Constipation (OlC) Drugs Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Opioid Induced Constipation (OlC) Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Opioid Induced Constipation (OlC) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Opioid Induced Constipation (OlC) Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Opioid Induced Constipation (OlC) Drugs Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Opioid Induced Constipation (OlC) Drugs Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Opioid Induced Constipation (OlC) Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Opioid Induced Constipation (OlC) Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Opioid Induced Constipation (OlC) Drugs Sales (K Units) by Type (2018-2024)
Table 51. Global Opioid Induced Constipation (OlC) Drugs Sales (K Units) by Type (2024-2029)
Table 52. Global Opioid Induced Constipation (OlC) Drugs Sales Market Share by Type (2018-2024)
Table 53. Global Opioid Induced Constipation (OlC) Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Opioid Induced Constipation (OlC) Drugs Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Opioid Induced Constipation (OlC) Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Opioid Induced Constipation (OlC) Drugs Revenue Market Share by Type (2018-2024)
Table 57. Global Opioid Induced Constipation (OlC) Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Opioid Induced Constipation (OlC) Drugs Price (US$/Unit) by Type (2018-2024)
Table 59. Global Opioid Induced Constipation (OlC) Drugs Price (US$/Unit) by Type (2024-2029)
Table 60. Global Opioid Induced Constipation (OlC) Drugs Sales (K Units) by Application (2018-2024)
Table 61. Global Opioid Induced Constipation (OlC) Drugs Sales (K Units) by Application (2024-2029)
Table 62. Global Opioid Induced Constipation (OlC) Drugs Sales Market Share by Application (2018-2024)
Table 63. Global Opioid Induced Constipation (OlC) Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Opioid Induced Constipation (OlC) Drugs Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Opioid Induced Constipation (OlC) Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Opioid Induced Constipation (OlC) Drugs Revenue Market Share by Application (2018-2024)
Table 67. Global Opioid Induced Constipation (OlC) Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Opioid Induced Constipation (OlC) Drugs Price (US$/Unit) by Application (2018-2024)
Table 69. Global Opioid Induced Constipation (OlC) Drugs Price (US$/Unit) by Application (2024-2029)
Table 70. Dr. Reddy's Laboratories Ltd. Corporation Information
Table 71. Dr. Reddy's Laboratories Ltd. Description and Business Overview
Table 72. Dr. Reddy's Laboratories Ltd. Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Dr. Reddy's Laboratories Ltd. Opioid Induced Constipation (OlC) Drugs Product
Table 74. Dr. Reddy's Laboratories Ltd. Recent Developments/Updates
Table 75. Bausch Health Companies Inc Corporation Information
Table 76. Bausch Health Companies Inc Description and Business Overview
Table 77. Bausch Health Companies Inc Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Bausch Health Companies Inc Opioid Induced Constipation (OlC) Drugs Product
Table 79. Bausch Health Companies Inc Recent Developments/Updates
Table 80. Pharmaceutical lndustries Ltd. Corporation Information
Table 81. Pharmaceutical lndustries Ltd. Description and Business Overview
Table 82. Pharmaceutical lndustries Ltd. Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Pharmaceutical lndustries Ltd. Opioid Induced Constipation (OlC) Drugs Product
Table 84. Pharmaceutical lndustries Ltd. Recent Developments/Updates
Table 85. Novartis AG Corporation Information
Table 86. Novartis AG Description and Business Overview
Table 87. Novartis AG Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Novartis AG Opioid Induced Constipation (OlC) Drugs Product
Table 89. Novartis AG Recent Developments/Updates
Table 90. Takeda Pharmaceutical Company Limited Corporation Information
Table 91. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 92. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OlC) Drugs Product
Table 94. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 95. Shionogi & Co., Ltd. Corporation Information
Table 96. Shionogi & Co., Ltd. Description and Business Overview
Table 97. Shionogi & Co., Ltd. Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Shionogi & Co., Ltd. Opioid Induced Constipation (OlC) Drugs Product
Table 99. Shionogi & Co., Ltd. Recent Developments/Updates
Table 100. Mallinckrodt Plc Corporation Information
Table 101. Mallinckrodt Plc Description and Business Overview
Table 102. Mallinckrodt Plc Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Mallinckrodt Plc Opioid Induced Constipation (OlC) Drugs Product
Table 104. Mallinckrodt Plc Recent Developments/Updates
Table 105. Merck & Co, Inc. Corporation Information
Table 106. Merck & Co, Inc. Description and Business Overview
Table 107. Merck & Co, Inc. Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Merck & Co, Inc. Opioid Induced Constipation (OlC) Drugs Product
Table 109. Merck & Co, Inc. Recent Developments/Updates
Table 110. Astra Zeneca Plc Corporation Information
Table 111. Astra Zeneca Plc Description and Business Overview
Table 112. Astra Zeneca Plc Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Astra Zeneca Plc Opioid Induced Constipation (OlC) Drugs Product
Table 114. Astra Zeneca Plc Recent Developments/Updates
Table 115. Cosmo Pharmaceuticals Corporation Information
Table 116. Cosmo Pharmaceuticals Description and Business Overview
Table 117. Cosmo Pharmaceuticals Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Cosmo Pharmaceuticals Opioid Induced Constipation (OlC) Drugs Product
Table 119. Cosmo Pharmaceuticals Recent Developments/Updates
Table 120. Teva Corporation Information
Table 121. Teva Description and Business Overview
Table 122. Teva Opioid Induced Constipation (OlC) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Teva Opioid Induced Constipation (OlC) Drugs Product
Table 124. Teva Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Opioid Induced Constipation (OlC) Drugs Distributors List
Table 128. Opioid Induced Constipation (OlC) Drugs Customers List
Table 129. Opioid Induced Constipation (OlC) Drugs Market Trends
Table 130. Opioid Induced Constipation (OlC) Drugs Market Drivers
Table 131. Opioid Induced Constipation (OlC) Drugs Market Challenges
Table 132. Opioid Induced Constipation (OlC) Drugs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Opioid Induced Constipation (OlC) Drugs
Figure 2. Global Opioid Induced Constipation (OlC) Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Opioid Induced Constipation (OlC) Drugs Market Share by Type in 2022 & 2029
Figure 4. Over the Counter Drugs Product Picture
Figure 5. Prescribed Drugs Product Picture
Figure 6. Global Opioid Induced Constipation (OlC) Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Opioid Induced Constipation (OlC) Drugs Market Share by Application in 2022 & 2029
Figure 8. Clinic
Figure 9. Hospital
Figure 10. Others
Figure 11. Global Opioid Induced Constipation (OlC) Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Opioid Induced Constipation (OlC) Drugs Market Size (2018-2029) & (US$ Million)
Figure 13. Global Opioid Induced Constipation (OlC) Drugs Sales (2018-2029) & (K Units)
Figure 14. Global Opioid Induced Constipation (OlC) Drugs Average Price (US$/Unit) & (2018-2029)
Figure 15. Opioid Induced Constipation (OlC) Drugs Report Years Considered
Figure 16. Opioid Induced Constipation (OlC) Drugs Sales Share by Manufacturers in 2022
Figure 17. Global Opioid Induced Constipation (OlC) Drugs Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Opioid Induced Constipation (OlC) Drugs Players: Market Share by Revenue in 2022
Figure 19. Opioid Induced Constipation (OlC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Opioid Induced Constipation (OlC) Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Opioid Induced Constipation (OlC) Drugs Sales Market Share by Country (2018-2029)
Figure 22. North America Opioid Induced Constipation (OlC) Drugs Revenue Market Share by Country (2018-2029)
Figure 23. United States Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Opioid Induced Constipation (OlC) Drugs Sales Market Share by Country (2018-2029)
Figure 26. Europe Opioid Induced Constipation (OlC) Drugs Revenue Market Share by Country (2018-2029)
Figure 27. Germany Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Opioid Induced Constipation (OlC) Drugs Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Opioid Induced Constipation (OlC) Drugs Revenue Market Share by Region (2018-2029)
Figure 34. China Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Opioid Induced Constipation (OlC) Drugs Sales Market Share by Country (2018-2029)
Figure 42. Latin America Opioid Induced Constipation (OlC) Drugs Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Colombia Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Opioid Induced Constipation (OlC) Drugs Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Opioid Induced Constipation (OlC) Drugs Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Opioid Induced Constipation (OlC) Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Opioid Induced Constipation (OlC) Drugs by Type (2018-2029)
Figure 53. Global Revenue Market Share of Opioid Induced Constipation (OlC) Drugs by Type (2018-2029)
Figure 54. Global Opioid Induced Constipation (OlC) Drugs Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Opioid Induced Constipation (OlC) Drugs by Application (2018-2029)
Figure 56. Global Revenue Market Share of Opioid Induced Constipation (OlC) Drugs by Application (2018-2029)
Figure 57. Global Opioid Induced Constipation (OlC) Drugs Price (US$/Unit) by Application (2018-2029)
Figure 58. Opioid Induced Constipation (OlC) Drugs Value Chain
Figure 59. Opioid Induced Constipation (OlC) Drugs Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed